Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | Cellular & Molecular Biology Letters

Fig. 2

From: FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism

Fig. 2

Relationship between FFAR4 expression and patient overall survival in patients with LUAD. A Kaplan–Meier plot of the expression level of FFAR4 in the overall cohort of patients with LUAD. BI Subgroup analyses for patients with T stage: T3 and T4; N stage: N0, N1, and N2; M stage: M0; pathological stage: stage I, II, and III; pathological stage: stage II; residual tumor: R0 and R1; anatomic neoplasm subdivision: left; and age: ≤ 65 years old. J A nomogram that predicts the 1-, 3-, and 5-year survival rate of patients with LUAD

Back to article page